PULSE › Topics › Phase 3 Trials
Phase 3 Trials
3 trends tracked about this subject — the full history, oldest to newest below.
↑ Rising
Business
FDA scientists are disputing efficacy claims regarding Capricor Therapeutics' Phase 3 Duchenne muscular dystrophy cell therapy, triggering a stock plunge.
6 sources
6 articles
v 18
3h ago
◼ Archived
Business
🔮 fades
Eli Lilly's retatrutide shows significant weight loss results in Phase 3 trials, paving the way for a 2027 FDA approval filing.
6 sources
6 articles
v 4
3d ago
◼ Archived
Business
🔮 fades
Eli Lilly is moving toward 2027 regulatory filings for retatrutide after successful Phase 3 obesity trials showing significant weight and A1C improvements.
5 sources
5 articles
v 3
4d ago